Market Overview

Keybanc Says Tesla Deliveries Tracking Above Estimates, Raises Model 3 Deliveries Forecast To 30,000

Keybanc Says Tesla Deliveries Tracking Above Estimates, Raises Model 3 Deliveries Forecast To 30,000

Tesla Inc (NASDAQ: TSLA)’s stock has stood strong in the month leading up to the quarter’s end. One analyst found such strength is performance-backed.

The Rating

KeyBanc Capital Markets analyst Brad Erickson maintained a Sector Weight rating.

The Thesis

KeyBanc’s store checks found Model 3 deliveries tracking about 50 percent higher than projections and achieving “meaningful ramp.”

By Erickson’s latest estimates, Tesla is on pace to deliver 30,000 to 35,000 in the second quarter, and he accordingly raised his forecast from between 20,000 and 25,000 to 30,000.

He additionally increased 2018 deliveries estimates from 98,182 to 118,182 and reiterated expectations for positive Model 3 gross margins in the third quarter.

“While the longer-term debate on TSLA remains more balanced, keeping us Sector Weight, we maintain that evidence supporting the bear case is not likely to emerge in the near term, in our view,” Erickson wrote, referencing softened demand or poor production ramping.

The analyst remains undeterred by anecdotes around safety quality and anticipates consumer perceptions improving.

Price Action

At time of publication, Tesla shares were trading up 2.5 percent at a rate of $340.27.

Related Links:

Musk Says Tesla Targets August Date For Updates Foundational To Autonomy

Morgan Stanley Isn't Buying Tesla's Claims For Profitability, Positive Cash Flow, China Prospects

Latest Ratings for TSLA

Oct 2019DowngradesMarket OutperformMarket Perform
Sep 2019Initiates Coverage OnBuy
Jul 2019ReiteratesUnderweight

View More Analyst Ratings for TSLA
View the Latest Analyst Ratings

Posted-In: Brad Erickson KeyBanc Capital Markets Model 3Analyst Color Reiteration Top Stories Analyst Ratings Best of Benzinga


Related Articles (TSLA)

View Comments and Join the Discussion!

Latest Ratings

FTVMorgan StanleyMaintains70.0
ROKMorgan StanleyMaintains142.0
WWEFBN SecuritiesUpgrades100.0
SWNCapital One FinancialUpgrades
AEISCowen & Co.Downgrades57.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate

26 Stocks Moving In Tuesday's Pre-Market Session